IP Verse

Prolyl Hydroxylase Inhibitors And Methods Of Use - EP3357911

PATENT ANALYSIS

Patent Details

Grant Date
May 11, 2022
Company
AKEBIA THERAPEUTICS INC.
Oppositions

FIBROGEN, INC.

More patents of Akebia Therapeutics Inc.

EP3357911

Want to monitor this patent?

Feel free to send us a message here and we will get back to you